ArticleOncotarget2018

Chemopreventative celecoxib fails to prevent schwannoma formation or sensorineural hearing loss in genetically engineered murine model of neurofibromatosis type 2.

Benjamin M Wahle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.